Vitamin Shoppe, Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats. The direct segment sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com. The manufacturing segment provides custom manufacturing and private labeling of vitamin, mineral and supplement products, and develops and markets its own branded products for both sales to third parties and for the VSI product assortment. As of December 31, 2016, it marketed approximately 900 brands, as well as its own brands. As of December 31, 2016, it operated 775 stores located in 45 states, the District of Columbia and Puerto Rico, primarily located in retail centers and standalone locations.
Industry, Sector and Symbol:
- Sector: Retail/Wholesale
- Industry: Health Food Stores
- Sub-Industry: Specialty Stores
- Symbol: NYSE:VSI
- CUSIP: 92849E10
- Web: www.vitaminshoppe.com
Capitalization:- Market Cap: $250.16 million
- Outstanding Shares: 23,163,000
Average Prices:- 50 Day Moving Avg: $11.16
- 200 Day Moving Avg: $17.12
- 52 Week Range: $9.80 - $32.31
P/E:- Trailing P/E Ratio: 13.58
- Foreward P/E Ratio: 6.43
- P/E Growth: -1.67
Sales & Book Value:- Annual Revenue: $1.27 billion
- Price / Sales: 0.20
- Book Value: $19.48 per share
- Price / Book: 0.55
Profitability:- EBIDTA: $108.63 million
- Net Margins: 1.43%
- Return on Equity: 9.35%
- Return on Assets: 5.73%
Debt:- Debt-to-Equity Ratio: 0.27%
- Current Ratio: 2.35%
- Quick Ratio: 0.31%
Misc:- Average Volume: 506,592 shs.
- Beta: 0.69
- Short Ratio: 7.83
Frequently Asked Questions for Vitamin Shoppe (NYSE:VSI)
What is Vitamin Shoppe's stock symbol?
Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."
How were Vitamin Shoppe's earnings last quarter?
Vitamin Shoppe, Inc (NYSE:VSI) posted its quarterly earnings data on Wednesday, May, 10th. The company reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.21. The company earned $316.90 million during the quarter, compared to the consensus estimate of $325.71 million. Vitamin Shoppe had a net margin of 1.43% and a return on equity of 9.35%. The company's revenue was down 5.9% on a year-over-year basis. During the same quarter last year, the business earned $0.67 earnings per share. View Vitamin Shoppe's Earnings History.
When will Vitamin Shoppe make its next earnings announcement?
What guidance has Vitamin Shoppe issued on next quarter's earnings?
Vitamin Shoppe issued an update on its FY17 earnings guidance on Wednesday, May, 10th. The company provided EPS guidance of $1.50-1.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.04.
Where is Vitamin Shoppe's stock going? Where will Vitamin Shoppe's stock price be in 2017?
7 equities research analysts have issued 1-year target prices for Vitamin Shoppe's stock. Their predictions range from $13.00 to $39.00. On average, they anticipate Vitamin Shoppe's stock price to reach $23.50 in the next twelve months. View Analyst Ratings for Vitamin Shoppe.
Who are some of Vitamin Shoppe's key competitors?
Some companies that are related to Vitamin Shoppe include Fiesta Restaurant Group (FRGI), Regis Corporation (RGS), Haverty Furniture Companies (HVT), Express (EXPR), Carrols Restaurant Group (TAST), Lands' End (LE), Overstock.com (OSTK), Chuy's Holdings (CHUY), Ascena Retail Group (ASNA), Titan Machinery (TITN), Pier 1 Imports (PIR), Fogo de Chao (FOGO), MarineMax (HZO), Vera Bradley (VRA), Jumei International Holding Limited (JMEI), The Habit Restaurants (HABT), Citi Trends (CTRN) and Shoe Carnival (SCVL).
Who are Vitamin Shoppe's key executives?
Vitamin Shoppe's management team includes the folowing people:
- Colin Frederick Watts, Chief Executive Officer, Director
- Brenda M. Galgano CPA, Chief Financial Officer, Executive Vice President
- Michael A. Jaffe, Interim General Counsel, Corporate Secretary
- John D. Bowlin, Lead Independnt Director
- B. Michael Michael Becker CPA, Independent Director
- Deborah M. Derby, Independent Director
- Tracy Dolgin, Independent Director
- David H. Edwab CPA, Independent Director
Who owns Vitamin Shoppe stock?
Vitamin Shoppe's stock is owned by a number of of retail and institutional investors. Top institutional investors include Financial & Investment Management Group Ltd. (0.62%), Aperio Group LLC (0.15%), Russell Investments Group Ltd. (0.12%) and Capstone Asset Management Co. (0.06%). Company insiders that own Vitamin Shoppe stock include B Michael Becker, Dan Lamadrid, Guillermo Marmol and Richard L Markee. View Institutional Ownership Trends for Vitamin Shoppe.
Who bought Vitamin Shoppe stock? Who is buying Vitamin Shoppe stock?
Vitamin Shoppe's stock was bought by a variety of institutional investors in the last quarter, including Financial & Investment Management Group Ltd., Aperio Group LLC, Russell Investments Group Ltd. and Capstone Asset Management Co.. View Insider Buying and Selling for Vitamin Shoppe.
How do I buy Vitamin Shoppe stock?
Shares of Vitamin Shoppe can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Vitamin Shoppe's stock price today?
One share of Vitamin Shoppe stock can currently be purchased for approximately $10.80.
MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Vitamin Shoppe (NYSE:VSI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 5 Hold Ratings, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | $23.50 (117.59% upside) |
Analysts' Ratings History for Vitamin Shoppe (NYSE:VSI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 5/14/2017 | Barclays PLC | Reiterated Rating | Equal Weight | $24.00 -> $13.00 | Low |  |
| 5/11/2017 | Gabelli | Downgrade | Buy -> Hold | | Medium | |
| 5/11/2017 | Morgan Stanley | Upgrade | Underweight -> Equal Weight | $14.00 | High | |
| 3/23/2017 | Goldman Sachs Group, Inc. (The) | Lower Price Target | Sell | $22.00 -> $19.00 | Low | |
| 10/27/2016 | J P Morgan Chase & Co | Downgrade | Overweight -> Neutral | $33.00 -> $28.00 | N/A | |
| 9/26/2016 | Jefferies Group LLC | Reiterated Rating | Hold | $28.00 | N/A | |
| 8/3/2016 | Wedbush | Reiterated Rating | Outperform | $39.00 | N/A | |
| 5/16/2016 | Robert W. Baird | Reiterated Rating | Hold | | N/A | |
| 5/16/2016 | Sterne Agee CRT | Reiterated Rating | Neutral | | N/A | |
| 5/5/2016 | Macquarie | Reiterated Rating | Neutral | $40.00 | N/A | |
| 4/15/2016 | Piper Jaffray Companies | Reiterated Rating | Neutral | $30.00 | N/A | |
| 3/28/2016 | William Blair | Downgrade | Market Perform | | N/A | |
| 2/24/2016 | Deutsche Bank AG | Reiterated Rating | Hold | $37.00 -> $30.00 | N/A | |
| 12/13/2015 | Bank of America Corporation | Reiterated Rating | Underperform | $26.00 -> $28.00 | N/A | |
| 8/7/2015 | Tigress Financial | Downgrade | Buy -> Neutral | | N/A | |
(Data available from 7/26/2015 forward)
Earnings History for Vitamin Shoppe (NYSE:VSI)Earnings History by Quarter for Vitamin Shoppe (NYSE VSI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/1/2017 | | $0.40 | | | | | N/A | |
| 5/10/2017 | Q1 2017 | $0.58 | $0.37 | $325.71 million | $316.90 million | View | N/A | |
| 3/1/2017 | Q416 | $0.40 | $0.36 | $311.79 million | $304.87 million | View | Listen | |
| 11/2/2016 | Q316 | $0.50 | $0.50 | $317.18 million | $314.90 million | View | N/A | |
| 8/3/2016 | Q216 | $0.59 | $0.55 | $331.58 million | $332.70 million | View | N/A | |
| 5/4/2016 | Q116 | $0.65 | $0.67 | $339.76 million | $336.80 million | View | N/A | |
| 2/23/2016 | Q415 | $0.38 | $0.39 | $294.17 million | $293.50 million | View | Listen | |
| 11/4/2015 | Q315 | $0.47 | $0.52 | $317.28 million | $313.90 million | View | N/A | |
| 8/5/2015 | Q215 | $0.54 | $0.57 | $325.78 million | $322.30 million | View | N/A | |
| 5/6/2015 | Q115 | $0.74 | $0.63 | $344.66 million | $336.80 million | View | N/A | |
| 2/24/2015 | Q414 | $0.41 | $0.41 | $294.77 million | $290.10 million | View | N/A | |
| 11/4/2014 | Q314 | $0.52 | $0.40 | $314.60 million | $308.90 million | View | N/A | |
| 8/5/2014 | Q214 | $0.63 | $0.62 | $306.09 million | $306.20 million | View | N/A | |
| 5/7/2014 | Q114 | $0.68 | $0.67 | $302.82 million | $307.80 million | View | N/A | |
| 2/25/2014 | Q413 | $0.38 | $0.37 | $253.87 million | $256.40 million | View | N/A | |
| 11/5/2013 | Q313 | $0.52 | $0.53 | $273.87 million | $272.50 million | View | N/A | |
| 8/6/2013 | Q2 2013 | $0.60 | $0.60 | $284.28 million | $279.50 million | View | Listen | |
| 5/7/2013 | Q1 2013 | $0.69 | $0.68 | $282.71 million | $279.10 million | View | Listen | |
| 2/26/2013 | Q4 2012 | $0.40 | $0.40 | $223.88 million | $218.90 million | View | Listen | |
| 11/6/2012 | Q312 | $0.46 | $0.54 | $234.66 million | $239.00 million | View | N/A | |
| 8/7/2012 | | $0.51 | $0.55 | | | View | N/A | |
| 5/8/2012 | | $0.57 | $0.61 | | | View | N/A | |
| 2/28/2012 | | $0.32 | $0.38 | | | View | N/A | |
| 10/26/2011 | | $0.33 | $0.41 | | | View | N/A | |
| 7/28/2011 | | $0.38 | $0.40 | | | View | N/A | |
| 4/26/2011 | | $0.40 | $0.47 | | | View | N/A | |
| 2/16/2011 | | $0.21 | $0.22 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Vitamin Shoppe (NYSE:VSI)2017 EPS Consensus Estimate: $2.40
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.75 | $0.79 | $0.77 |
| Q2 2017 | 2 | $0.59 | $0.64 | $0.62 |
| Q3 2017 | 2 | $0.53 | $0.57 | $0.55 |
| Q4 2017 | 2 | $0.43 | $0.50 | $0.47 |
(Data provided by Zacks Investment Research)
Dividend History for Vitamin Shoppe (NYSE:VSI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Vitamin Shoppe (NYSE:VSI)Insider Ownership Percentage: 1.07%
Insider Trades by Quarter for Vitamin Shoppe (NYSE:VSI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/8/2017 | B. Michael Becker | Director | Sell | 2,729 | $19.41 | $52,969.89 | |
| 3/3/2017 | Dan Lamadrid | CAO | Sell | 5,432 | $22.36 | $121,459.52 | |
| 3/3/2017 | Richard L Markee | Director | Sell | 100,000 | $22.24 | $2,224,000.00 | |
| 11/8/2016 | Dan Lamadrid | CAO | Sell | 1,734 | $23.20 | $40,228.80 | |
| 5/31/2016 | Guillermo Marmol | Director | Buy | 1,000 | $30.23 | $30,230.00 | |
| 11/14/2014 | Brenda Galgano | CFO | Sell | 5,000 | $48.77 | $243,850.00 | |
| 11/13/2014 | Richard L Markee | Insider | Sell | 27,774 | $47.79 | $1,327,319.46 | |
| 9/18/2014 | Anthony N Truesdale | CEO | Sell | 61,792 | $45.00 | $2,780,640.00 | |
| 9/18/2014 | Richard L Markee | Insider | Sell | 30,000 | $45.00 | $1,350,000.00 | |
| 9/12/2014 | Jean W Frydman | Insider | Sell | 1,135 | $43.40 | $49,259.00 | |
| 6/16/2014 | Richard L Markee | Chairman | Sell | 10,000 | $45.00 | $450,000.00 | |
| 6/11/2014 | Anthony Alfonso | Insider | Buy | 5,000 | $44.44 | $222,200.00 | |
| 5/1/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $47.18 | $1,651,300.00 | |
| 5/1/2014 | Richard Markee | Chairman | Sell | 10,000 | $47.18 | $471,800.00 | |
| 4/1/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $47.91 | $1,676,850.00 | |
| 4/1/2014 | Richard Markee | Insider | Sell | 10,000 | $47.91 | $479,100.00 | |
| 3/3/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $46.30 | $1,620,500.00 | |
| 3/3/2014 | Richard Markee | Insider | Sell | 10,000 | $46.29 | $462,900.00 | |
| 1/10/2014 | Anthony Truesdale | CEO | Sell | 35,000 | $48.51 | $1,697,850.00 | |
| 11/14/2013 | Richard Markee | Chairman | Sell | 50,000 | $52.48 | $2,624,000.00 | |
| 11/13/2013 | David Edwab | Director | Sell | 3,738 | $52.35 | $195,684.30 | |
| 2/28/2013 | B. Michael Becker | Director | Buy | 1,000 | $51.95 | $51,950.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Vitamin Shoppe (NYSE:VSI)
Latest Headlines for Vitamin Shoppe (NYSE:VSI)
| Source: |
|
| Date | Headline |
|---|
 | Vitamin Shoppe, Inc (VSI) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - July 25 at 7:32 AM |
| Vitamin Shoppe, Inc (VSI) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - July 18 at 11:59 AM |
| Vitamin Shoppe, Inc (VSI) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - July 17 at 6:40 PM |
| Vitamin Shoppe (VSI) versus Natural Grocers by Vitamin Cottage (NGVC) Head-To-Head Comparison
www.americanbankingnews.com - July 13 at 10:23 PM |
| Financial Analysis: Natural Grocers by Vitamin Cottage (NGVC) & Vitamin Shoppe (NYSE:VSI)
www.americanbankingnews.com - July 13 at 8:09 AM |
 | ETFs with exposure to Vitamin Shoppe, Inc. : July 7, 2017
finance.yahoo.com - July 8 at 4:50 PM |
| Reviewing Vitamin Shoppe (NYSE:VSI) & Natural Grocers by Vitamin Cottage (NGVC)
www.americanbankingnews.com - July 8 at 12:16 AM |
| $315.29 Million in Sales Expected for Vitamin Shoppe, Inc (VSI) This Quarter
www.americanbankingnews.com - July 5 at 11:50 AM |
| Zacks: Brokerages Expect Vitamin Shoppe, Inc (VSI) to Announce $0.39 Earnings Per Share
www.americanbankingnews.com - July 3 at 10:14 AM |
| Comparing Natural Grocers by Vitamin Cottage (NGVC) and Vitamin Shoppe (VSI)
www.americanbankingnews.com - June 29 at 10:32 PM |
| Head to Head Review: Vitamin Shoppe (VSI) vs. Natural Grocers by Vitamin Cottage (NGVC)
www.americanbankingnews.com - June 28 at 6:28 PM |
| Financial Review: Vitamin Shoppe (VSI) & Natural Grocers by Vitamin Cottage (NGVC)
www.americanbankingnews.com - June 28 at 7:52 AM |
| ETFs with exposure to Vitamin Shoppe, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 8:35 PM |
| Reviewing Natural Grocers by Vitamin Cottage (NGVC) & Vitamin Shoppe (VSI)
www.americanbankingnews.com - June 25 at 7:36 AM |
| Vitamin Shoppe, Inc. :VSI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 23, 2017
finance.yahoo.com - June 24 at 7:49 AM |
| Vitamin Shoppe, Inc (VSI) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - June 20 at 4:14 PM |
| Bear of the Day: Vitamin Shoppe (VSI)
finance.yahoo.com - June 19 at 8:24 AM |
| Vitamin Shoppe (VSI) versus Natural Grocers by Vitamin Cottage (NGVC) Critical Contrast
www.americanbankingnews.com - June 18 at 12:42 AM |
| Reviewing Vitamin Shoppe (VSI) and Natural Grocers by Vitamin Cottage (NGVC)
www.americanbankingnews.com - June 17 at 10:26 PM |
| Vitamin Shoppe Inc (VSI) Expected to Post Quarterly Sales of $315.29 Million
www.americanbankingnews.com - June 9 at 4:04 PM |
| Brokerages Anticipate Vitamin Shoppe Inc (VSI) Will Announce Earnings of $0.39 Per Share
www.americanbankingnews.com - June 7 at 8:06 AM |
| Forty Years of Thriving: The Vitamin Shoppe celebrates 40 years of health and wellness with a month-long celebration honoring its heritage and role as a leading omni-channel specialty retailer and lifestyle destination.
finance.yahoo.com - June 6 at 1:52 AM |
| Vitamin Shoppe Inc (VSI) Cut to "Hold" at ValuEngine
www.americanbankingnews.com - June 2 at 8:04 PM |
| Vitamin Shoppe Inc (VSI) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - May 26 at 4:52 PM |
| Gabelli Weighs in on Vitamin Shoppe Inc's FY2017 Earnings (VSI)
www.americanbankingnews.com - May 15 at 8:20 AM |
| Vitamin Shoppe Inc (VSI) Given "Equal Weight" Rating at Barclays PLC
www.americanbankingnews.com - May 14 at 4:00 PM |
| Vitamin Shoppe Inc (VSI) Upgraded at Morgan Stanley
www.americanbankingnews.com - May 14 at 8:47 AM |
| Vitamin Shoppe Inc (VSI) Lowered to Hold at Gabelli
www.americanbankingnews.com - May 13 at 11:56 PM |
| Vitamin Shoppe Inc (VSI) Downgraded to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - May 13 at 7:52 AM |
 | 6 Reasons Vitamin Shoppe Likely To Remain Under Pressure
feeds.benzinga.com - May 12 at 10:03 AM |
| Edited Transcript of VSI earnings conference call or presentation 10-May-17 12:30pm GMT
finance.yahoo.com - May 12 at 4:14 AM |
| Looking for a Deal? Vitamin Shoppe Is Not a Healthy Choice
finance.yahoo.com - May 12 at 4:14 AM |
| Vitamin Shoppe Inc (VSI) Expected to Announce Earnings of $0.40 Per Share
www.americanbankingnews.com - May 11 at 9:26 AM |
 | BRIEF-Vitamin Shoppe sees FY 2017 adjusted EPS $1.50-$1.75 excluding items
www.businessinsider.com - May 11 at 3:18 AM |
 | Vitamin Shoppe (VSI) Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 3:18 AM |
 | Shares of Vitamin Shoppe Inc. Plunge 32% After Big Earnings Miss
www.fool.com - May 10 at 4:29 PM |
| Vitamin Shoppe Inc (VSI) Posts Quarterly Earnings Results, Misses Expectations By $0.20 EPS
www.americanbankingnews.com - May 10 at 12:53 PM |
| Vitamin Shoppe, Inc. Announces First Quarter 2017 Results
finance.yahoo.com - May 10 at 9:55 AM |
| Vitamin Shoppe misses 1Q profit forecasts
finance.yahoo.com - May 10 at 9:55 AM |
| Vitamin Shoppe Inc (VSI) Issues FY17 Earnings Guidance
www.americanbankingnews.com - May 10 at 9:22 AM |
| Vitamin Shoppe Inc (VSI) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - May 8 at 9:41 AM |
| The Vitamin Shoppe Exclusive Retailer Of CrossFit Games Partner Paleoethics
finance.yahoo.com - May 5 at 3:26 AM |
| Vitamin Shoppe (VSI) Getting Somewhat Negative News Coverage, Study Shows
www.americanbankingnews.com - May 2 at 1:18 PM |
| Vitamin Shoppe Inc (VSI) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - May 1 at 8:06 PM |
| Vitamin Shoppe (VSI) Given Daily Coverage Optimism Rating of 0.21
www.americanbankingnews.com - April 29 at 10:48 AM |
| Vitamin Shoppe, Inc. Announces Fiscal First Quarter 2017 Earnings Release and Webcast Date
finance.yahoo.com - April 27 at 11:05 PM |
| Vitamin Shoppe, Inc. – Value Analysis (NYSE:VSI) : April 24, 2017
finance.yahoo.com - April 24 at 6:56 PM |
| Vitamin Shoppe (VSI) Given News Impact Score of 0.10
www.americanbankingnews.com - April 24 at 10:20 AM |
| Vitamin Shoppe Inc (VSI) Expected to Post Quarterly Sales of $323.25 Million
www.americanbankingnews.com - April 22 at 8:51 AM |
| Vitamin Shoppe, Inc. breached its 50 day moving average in a Bullish Manner : VSI-US : April 21, 2017
finance.yahoo.com - April 21 at 8:47 PM |
Vitamin Shoppe (VSI) Chart for Wednesday, July, 26, 2017
